Cargando…

Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism

Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated S...

Descripción completa

Detalles Bibliográficos
Autores principales: Oroszlán, Gábor, Dani, Ráhel, Szilágyi, András, Závodszky, Péter, Thiel, Steffen, Gál, Péter, Dobó, József
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741598/
https://www.ncbi.nlm.nih.gov/pubmed/29326707
http://dx.doi.org/10.3389/fimmu.2017.01821
_version_ 1783288206678032384
author Oroszlán, Gábor
Dani, Ráhel
Szilágyi, András
Závodszky, Péter
Thiel, Steffen
Gál, Péter
Dobó, József
author_facet Oroszlán, Gábor
Dani, Ráhel
Szilágyi, András
Závodszky, Péter
Thiel, Steffen
Gál, Péter
Dobó, József
author_sort Oroszlán, Gábor
collection PubMed
description Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated SPs (MASP)-1, and MASP-2, which are known to be present as proenzymes in blood. The third SP of the lectin pathway, MASP-3, was recently shown to be the major activator, and the exclusive “resting blood” activator of profactor D, producing factor D, the initiator protease of the alternative pathway. Because only activated MASP-3 is capable of carrying out this cleavage, it was presumed that a significant fraction of MASP-3 must be present in the active form in resting blood. Here, we aimed to detect active MASP-3 in the blood by a more direct technique and to quantitate the active to zymogen ratio. First, MASPs were partially purified (enriched) from human plasma samples by affinity chromatography using immobilized MBL in the presence of inhibitors. Using this MASP pool, only the zymogen form of MASP-1 was detected by Western blot, whereas over 70% MASP-3 was in an activated form in the same samples. Furthermore, the active to zymogen ratio of MASP-3 showed little individual variation. It is enigmatic how MASP-3, which is not able to autoactivate, is present mostly as an active enzyme, whereas MASP-1, which has a potent autoactivation capability, is predominantly proenzymic in resting blood. In an attempt to explain this phenomenon, we modeled the basal level fluid-phase activation of lectin pathway proteases and their subsequent inactivation by C1 inhibitor and antithrombin using available and newly determined kinetic constants. The model can explain extensive MASP-3 activation only if we assume efficient intracomplex activation of MASP-3 by zymogen MASP-1. On the other hand, the model is in good agreement with the fact that MASP-1 and -2 are predominantly proenzymic and some of them is present in the form of inactive serpin–protease complexes. As an alternative hypothesis, MASP-3 activation by proprotein convertases is also discussed.
format Online
Article
Text
id pubmed-5741598
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57415982018-01-11 Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism Oroszlán, Gábor Dani, Ráhel Szilágyi, András Závodszky, Péter Thiel, Steffen Gál, Péter Dobó, József Front Immunol Immunology Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated SPs (MASP)-1, and MASP-2, which are known to be present as proenzymes in blood. The third SP of the lectin pathway, MASP-3, was recently shown to be the major activator, and the exclusive “resting blood” activator of profactor D, producing factor D, the initiator protease of the alternative pathway. Because only activated MASP-3 is capable of carrying out this cleavage, it was presumed that a significant fraction of MASP-3 must be present in the active form in resting blood. Here, we aimed to detect active MASP-3 in the blood by a more direct technique and to quantitate the active to zymogen ratio. First, MASPs were partially purified (enriched) from human plasma samples by affinity chromatography using immobilized MBL in the presence of inhibitors. Using this MASP pool, only the zymogen form of MASP-1 was detected by Western blot, whereas over 70% MASP-3 was in an activated form in the same samples. Furthermore, the active to zymogen ratio of MASP-3 showed little individual variation. It is enigmatic how MASP-3, which is not able to autoactivate, is present mostly as an active enzyme, whereas MASP-1, which has a potent autoactivation capability, is predominantly proenzymic in resting blood. In an attempt to explain this phenomenon, we modeled the basal level fluid-phase activation of lectin pathway proteases and their subsequent inactivation by C1 inhibitor and antithrombin using available and newly determined kinetic constants. The model can explain extensive MASP-3 activation only if we assume efficient intracomplex activation of MASP-3 by zymogen MASP-1. On the other hand, the model is in good agreement with the fact that MASP-1 and -2 are predominantly proenzymic and some of them is present in the form of inactive serpin–protease complexes. As an alternative hypothesis, MASP-3 activation by proprotein convertases is also discussed. Frontiers Media S.A. 2017-12-18 /pmc/articles/PMC5741598/ /pubmed/29326707 http://dx.doi.org/10.3389/fimmu.2017.01821 Text en Copyright © 2017 Oroszlán, Dani, Szilágyi, Závodszky, Thiel, Gál and Dobó. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Oroszlán, Gábor
Dani, Ráhel
Szilágyi, András
Závodszky, Péter
Thiel, Steffen
Gál, Péter
Dobó, József
Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
title Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
title_full Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
title_fullStr Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
title_full_unstemmed Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
title_short Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
title_sort extensive basal level activation of complement mannose-binding lectin-associated serine protease-3: kinetic modeling of lectin pathway activation provides possible mechanism
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741598/
https://www.ncbi.nlm.nih.gov/pubmed/29326707
http://dx.doi.org/10.3389/fimmu.2017.01821
work_keys_str_mv AT oroszlangabor extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism
AT danirahel extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism
AT szilagyiandras extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism
AT zavodszkypeter extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism
AT thielsteffen extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism
AT galpeter extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism
AT dobojozsef extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism